This week’s research roundup summarizes three studies surrounding patient medical adherence in telemedicine. The studies explore the efficacy of telemedicine interventions in mental health, hypertension, and pulmonary arterial hypertension (PAH).
Study 1: Patient Medical Adherence. in Mental Health Care
The first study, a systematic review and meta-analysis, investigated the impact of telemedicine interventions on patient medical adherence to medicine in mental health care. Researchers identified nine randomized controlled trials involving 1,588 patients that met their inclusion criteria.
These trials evaluated telemedicine interventions, from automated reminders to video calls with healthcare providers and remote patient monitoring. The data revealed a small yet statistically significant improvement in medication adherence compared to usual care. (Hedges’s g = 0.25, 95% CI 0.12–0.38, p < 0.01). The effect size, although moderate, varied based on the type of mental disorder. The larger impact was observed in patients with depression (Hedges’s g = 0.29) compared to schizophrenia (Hedges’s g = 0.19).
Researchers found that incorporating telemedicine and remote monitoring into mental health services has the potential to enhance medication adherence rates. However, the researchers suggest further research into the most effective telemedicine approaches tailored to specific psychiatric conditions.
Study 2: A Multifaceted Approach to Hypertension Control: Bridging Gaps in Care
In the second study, a team of researchers addressed the challenge of patient medical adherence in individuals with uncontrolled high blood pressure. The approach involved remote blood pressure monitoring, regular video visits with pharmacists, and the support of community health workers. The study focused on 100 patients grappling with hypertension despite ongoing cardiologist intervention.
The results were promising but underscored the complexity of hypertension management. On average, patients experienced a significant decrease in blood pressure—20 points for systolic and 8 points for diastolic. However, only half of the patients reached the recommended goal of under 130/80 mmHg. The study identified factors associated with blood pressure control, including greater medication adherence, diabetes, and competing health priorities. Notably, no association was observed between social determinants of health (SDoH) and blood pressure control.
Collaborative care models can help to improve blood pressure control and fill in crucial gaps in traditional cardiologist care. The findings emphasized the need for continued efforts to refine and optimize such comprehensive interventions, ensuring more patients achieve optimal blood pressure levels.
Study 3: Patient medical Adherence in PAH Management
The third study explores patient medical adherence, focusing on individuals with pulmonary arterial hypertension (PAH), a rare chronic disease. The digital health program in the study encompassed an app for health tracking, educational content, medication reminders, and health coaching. Engaging 53 PAH patients across five hospitals in Spain, the study spanned six months, evaluating the program’s impact on quality of life, clinical outcomes, and patient satisfaction.
The digital program did not significantly improve quality of life or clinical outcomes. However, data showed patient engagement with the digital tools was exceptionally high. Ninety-six percent of patients actively logged health activities in the app, launching it an average of 1500 times monthly. Almost half of the patients completed at least two levels of educational content. While a substantial majority used the app consistently every month. Additionally, patients reported steady communication with the health coach. Moreover, 92% expressed satisfaction with the program and 95% expressed a willingness to recommend it to others with PAH.
Despite the limited clinical impact, the study concluded that the digital program empowered patients by providing them with the tools and resources for active participation in their healthcare journey. The high satisfaction rates and positive recommendations underscore the potential for digital health to play a crucial role in supporting individuals with less common diseases, paving the way for future optimization and enhancement of these tools.
Understanding Adherence
In these three distinct but interconnected studies in patient medical adherence, a common thread emerges—the potential of telemedicine in healthcare delivery. From mental health to hypertension and rare diseases like PAH, telemedicine offers a spectrum of solutions that can be tailored to diverse patient needs. The quantitative evidence supports the efficacy of telemedicine in improving medication adherence for mental health patients is complemented by the nuanced insights from hypertension and PAH studies, highlighting the multifaceted nature of healthcare challenges.
However, it is essential to acknowledge the inherent complexities and ongoing areas of improvement. The hypertension study also serves as a reminder of the intricacies involved in achieving optimal blood pressure control. Similarly, the PAH study raises questions about the balance between high patient engagement and measurable clinical impact, pointing towards the need for continuous refinement of digital health tools.
For more weekly insights into new telemedicine research studies, scroll down now to subscribe to Tenovi’s Weekly Research Round-Up. If you are part of a chronic care management, telehealth, or RPM software and services company, explore Tenovi RPM solutions. Book your free demo and consultation with us today.
